Major persistent 5' terminally deleted coxsackievirus B3 populations in human endomyocardial tissues.
In September 2011, a 47-year-old immune-competent woman was referred to University Hospital Center of Reims, Reims, France, because of stage 2 dyspnea (per New York Heart Association functional classifications, http://professional. heart.org/professional/General/UCM_423811_Classification-of-Functional-Capacity-and-Objective-Assessment.jsp) that began 1 month before. Transthoracic echocardiogram revealed a decreased left ventricle ejection fraction (LVEF) (45%) and a dilated left ventricle with a telediastolic diameter of 36 mm/[m.sup.2]. Coronary artery disease was ruled out by coronarography; no other etiologic causes of DCM were indicated by heart magnetic resonance imaging (2). Endomyocardial biopsies (n = 5) were performed at the time of hospitalization to assess the potential causes of IDCM (8). Classical and immunohistologic analyses indicated only a slight cardiomyocyte hypertrophy without myocarditis per the Dallas criteria (8). The clinical outcome was good, with a slight LVEF increase (54%) 4 years later after symptomatic treatment by b-blocker, therefore excluding the hypothesis of familial DCM.
Total nucleic acids were retrospectively extracted from flash-frozen cardiac tissues by using NucliSens easyMAG instrument protocols (bioMerieux, Marcy l'Etoile, France) according to the manufacturer's instructions. Real-time quantitative reverse transcription PCR was performed for quantitative detection of total and strand-specific EV-genus genomic RNA according to previously published protocols (7). Generic EV-genus real-time quantitative reverse transcription PCR protocols showed the presence of EV total RNA detection with a low viral load of 8.102/pg of total extracted nucleic acids and a low viral RNA positive-sense (RNA+) to RNA negative-sense (RNA-) ratio value of 4.8 (7).
Classical reverse transcription PCR sequencing of the viral protein 2 puff region enabled us to perform a genotypic identification of an original CV-B3 strain (GenBank accession no. KU608309); nucleotide and amino acid sequence homologies were 79% and 92%, respectively, with the CV-B3 Nancy strain (GenBank accession no. JX312064.1) (3,9). The genomic differences between the sample virus and the prototype strains ruled out the possibility of laboratory contamination events (10).
To identify the 5' NCR terminal deletion, we performed a rapid amplification of cDNA ends (RACE) PCR followed by an in-house NGS strategy. RNA-backboned oligonucleotides (trP1 and trPlc) were linked on 5' extremity of EV RNA+ and 3' extremity of RNA-, respectively (Table). A retrotranscription step was then performed by using trP1 or AvcRev for a specific hybridization on viral RNA- or RNA+, respectively (Table). For the RACE PCR strategy, the amplification step was performed by using AvcRev and trP1 primers. For the NGS strategy, the amplicons were generated by using 2 successive PCRs (forward primers: A+AvcRevBC2-1 and A+AvcRevBC2-2 for the first and second PCRs, respectively; reverse primer: trP1) (Table; online Technical Appendix, http://wwwnc.cdc.gov/EID/artide/22/8/16-0186-Techapp1. pdf). The libraries obtained were sequenced by using an Ion PGM sequencer (Life Technologies, Saint Aubin, France) according to the manufacturer's instructions. Only reads containing both A and trP1 sequences were selected and aligned against the 5' NCR regions of human EV genomes by using CLC Genomics Workbench software version 8.5.1 (CLC Bio, Aarhus, Denmark).
Our results estimated a major proportion (84.8%) of reads presenting with a terminal 48-nt deletion associated with minor proportions of reads deleted of 15 nt (14.3%) and nondeleted (0.9%) (Figure). Because read lengths could induce variation in the amplification efficiency, our NGS strategy corresponded to a semi-quantitative detection of the EV populations. We concluded that the persistent viral population in the cardiac samples consisted of a major proportion of deleted populations, with deletions ranging in size from 15 to 48 nt (Figure).
Our study demonstrated the existence of major 5' terminally deleted CV-B3 populations in endomyocardial tissues taken from a patient with IDCM at the time of her clinical diagnosis. We observed low viral RNA load values associated with a low viral RNA+ to RNA- ratio (<5), indicating that these viral forms were compatible with persistent endomyocardial EV-B populations (7).
One previous study reported a detection of 5' terminally deleted CV-B2 populations ranging in size from 22 to 36 nt in cardiac tissues taken from an immune competent patient in Japan who died of fulminant myocarditis (3). We demonstrated the existence of major persistent cardiac EV-B viral populations characterized by 15 and 48 nt deletions in the 5' NCR at the time of chronic DCM (Figure). These deletions induce a loss of a part of the 5' untranslated region cloverleaf structure, but the viral RNA polymerase (3CD) binding site remains intact (11). Such terminally deleted populations have been previously described in persistent murine cardiac infection characterized by low RNA+ to RNA- ratio associated with a low production level of infectious particles in cell cultures. Furthermore, murine and in vitro models have demonstrated that EV-2A proteinase is sufficient to induce DCM (12,13). As a result, low replicative terminally deleted viral forms could be generated and selected in heart tissues during the early acute viral replication phase (myocarditis) and could establish an ongoing persistent human cardiac infection leading to chronic myocarditis and the DCM clinical phase. Moreover, the NGS strategy showed that these 5' terminally deleted populations were associated with a minor full-length virus population, which could potentially affect persistence by acting as a helper virus through genomic transcomplementation (14) or genomic recombination mechanisms (15). Persistent low replicative EV-B deleted and undeleted collaborative populations might contribute to the pathogenesis of unexplained DCM cases.
The clinical data associated with our molecular results argued for a CV-B3-induced DCM stage that developed several years after an undiagnosed clinical CV-B3-related myocarditis event. Taken together with the unique published CV-B2-induced myocarditis case, our findings support the hypothesis that the emergence and the selection of terminally deleted EV-B forms could occur during the early acute viral replication phase and might explain the pathophysiological progression from acute viral myocarditis to the DCM phase, in which cardiac persistent terminally deleted virus populations would be advantaged (3). Further NGS investigations on a large number of cardiac tissues of myocarditis and DCM adult patients might enable a better understanding of the molecular mechanisms implicated in cardiac EV persistence.
Authors affiliations: University of Reims Champagne-Ardenne, Reims, France (A. Bouin, Y. Nguyen, M. Wehbe, F. Renois, P. Fornes, F. Bani-Sadr, L. Andreoletti); Centre Hospitalier Universitaire de Reims, France (Y. Nguyen, F. Renois, P. Fornes, F. Bani-Sadr, D. Metz, L. Andreoletti); Centre Azm pour la Recherche en Biotechnologie et ses Applications, Tripoli, Lebanon (M. Wehbe)
We thank A. Rico and S. Jankowsky for their expertise and skillful assistance with the NGS Ion Torrent Sequencing Protocol and analyses of the next-generation sequencing data.
A.B. was supported by a French Research Ministry grant. Support for this research was provided by a local grant from the Universite de Reims Champagne Ardenne.
Dr. Bouin is currently a postdoctoral fellow in the Department of Microbiology and Molecular Genetics at the University of California, Irvine, CA, USA. His primary research interests include persistent coxsackievirus replication and enterovirus terminal deletion mechanisms.
(1.) Racaniello VR. Picornaviridae: the viruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology, vol. 1. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 795-838.
(2.) Dennert R, Crijns HJ, Heymans S. Acute viral myocarditis. Eur Heart J. 2008; 29:2073-82. http://dx.doi.org/10.1093/eurheartj/ehn296
(3.) Chapman NM, Kim K-S, Drescher KM, Oka K, Tracy S. 5' terminal deletions in the genome of a coxsackievirus B2 strain occurred naturally in human heart. Virology. 2008; 375:480-91. http://dx.doi.org/10.1016/j.virol.2008.02.030
(4.) Arbustini E, Grasso M, Porcu E, Bellini O, Diegoli M, Fasani R, et al. Enteroviral RNA and virus-like particles in the skeletal muscle of patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 1997; 80:1188-93. http://dx.doi.org/10.1016/ S0002-9149(97)00638-3
(5.) Kim JKS, Zhu Z, Casale G, Koutakis P, McComb RD, Swanson S, et al. Human enterovirus in the gastrocnemius of patients with peripheral arterial disease. J Am Heart Assoc. 2013; 2:e000082. http://dx.doi.org/10.1161/jaha.113.000082
(6.) Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein VP1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia. 2009; 52:1143-51. http://dx.doi.org/10.1007/s00125-009-1276-0
(7.) Leveque N, Renois F, Talmud D, Nguyen Y, Lesaffre F, Boulagnon C, et al. Quantitative genomic and antigenomic enterovirus RNA detection in explanted heart tissue samples from patients with end-stage idiopathic dilated cardiomyopathy. J Clin Microbiol. 2012; 50:3378-80. http://dx.doi.org/10.1128/jcm.01612-12
(8.) Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. J Am Coll Cardiol. 2007; 50: 1914-31. http://dx.doi.org/10.1016/jjacc.2007.09.008
(9.) Nasri D, Bouslama L, Omar S, Saoudin H, Bourlet T, Aouni M, et al. Typing of human enterovirus by partial sequencing of VP2. J Clin Microbiol. 2007; 45:2370-9. http://dx.doi.org/10.1128/ jcm.00093-07
(10.) Oberste MS, Maher K, Kilpatrick DR, Pallansch MA. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol. 1999; 73:1941-8.
(11.) Sharma N, Ogram SA, Morasco BJ, Spear A, Chapman NM, Flanegan JB. Functional role of the 5' terminal cloverleaf in Coxsackievirus RNA replication. Virology. 2009; 393:238-49. http://dx.doi.org/10.1016j.virol.2009.07.039
(12.) Wessely R, Klingel K, Santana LF, Dalton N, Hongo M, Jonathan Lederer W, et al. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest. 1998; 102:1444-53. http://dx.doi.org/10.1172/jci1972
(13.) Xiong D, Yajima T, Lim B-K, Stenbit A, Dublin A, Dalton ND, et al. Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy. Circulation. 2007; 115:94-102. http://dx.doi.org/10.1161/circulationaha.106.631093
(14.) Collis PS, O'Donnell BJ, Barton DJ, Rogers JA, Flanegan JB. Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells. J Virol. 1992; 66:6480-8.
(15.) Holmblat B, Jegouic S, Muslin C, Blondel B, Joffret M-L, Delpeyroux F. Nonhomologous recombination between defective poliovirus and coxsackievirus genomes suggests a new model of genetic plasticity for picornaviruses. MBio. 2014; 5:e01119-14. http://dx.doi.org/10.1128/mbio.01119-14
Address for correspondence: Laurent Andreoletti, Laboratoire de Virologie Medicale et Moleculaire, CHU de Reims et EA-4684, SFR CAP-SANTE, URCA, Av General Koenig, 51100 Reims CEDEX, France; email: firstname.lastname@example.org
Table. Primer sequences used to detect and identify 5' terminal deletions in enterovirus populations detected in cardiac tissue of a patient with idiopathic dilated cardiomyopathy, Reims, France, September 2011 Primers Oligonucleotide sequences trP1 RNA * 5'H-CCTCTCTATGGGCAGTCGGTGAT-3' trP1c RNA * 5'P-ATCACCGACTGCCCATAGAGAGG-3'H trP1 5-CCT CTC TAT GGG CAG TCG GTG AT-3' AvcRev 5'-AACAGGCGCACAAAGCTACCG-3' A+AvcRevBC2-1 5'-CGACTCAGTAAGGAGAACGATAACAGGCGCACAAAGCTACCG-3' A+Avc RevB C2-2 5'-CCATCTCATCCCTGCGTGTCTCCGACTCAGTAAGGAGAACGATAAC-3' * RNA backbone oligonucleotides.
Please note: Some tables or figures were omitted from this article.
|Printer friendly Cite/link Email Feedback|
|Author:||Bouin, Alexis; Nguyen, Yohan; Wehbe, Michel; Renois, Fanny; Fornes, Paul; Bani-Sadr, Firouze; Metz,|
|Publication:||Emerging Infectious Diseases|
|Date:||Aug 1, 2016|
|Previous Article:||Human tick-borne encephalitis and characterization of virus from biting tick.|
|Next Article:||Seroconversions for Coxiella and rickettsial pathogens among US marines deployed to Afghanistan, 2001-2010.|